论文部分内容阅读
1病例报告患者男,46岁,因“腹胀1年,诊断为胰腺癌并综合治疗11个月”于2014-10-20就诊于山东大学附属山东省肿瘤医院。患者既往体健,2013-09无明显诱因出现腹胀不适,伴上腹部间歇性隐痛,与饮食及体位无关,后腹胀逐渐加重,于2013-09-13就诊于当地医院。腹部B超示“胰腺占位性病变,肝脏多发实性占位”。腹部CT检查示,胰头部占位,肝门部及腹膜后多发肿大淋巴结,符合胰腺癌肝转移CT表现。查血示,CA199 51.9U/mL(正常范围0~39U/mL),诊断为胰腺癌并肝内多发转移,临床分期cT3N1M1,Ⅳ期。2013-10-01于外院应用吉西他滨(江苏豪森药业集团有限公司,批号:H20030104)1.8g静脉滴入,d1、d8;
A case report male, 46 years old, due to “bloating for 1 year, the diagnosis of pancreatic cancer and comprehensive treatment of 11 months ” in 2014-10-20 visited the Shandong Provincial Tumor Hospital Affiliated to Shandong University. Patients with previous physical health, 2013-09 No obvious incentive to have abdominal distension and discomfort, accompanied by intermittent abdominal pain, with nothing to do with diet and body position, post-abdominal distention gradually aggravated, at 2013-09-13 Visit a local hospital. Abdomen B ultrasound shows “pancreatic space occupying lesions, multiple liver solid occupy ”. Abdominal CT examination shows that the head of the pancreas occupies the site of the hilar and multiple retroperitoneal lymph nodes, in line with the performance of pancreatic metastases of liver metastases. Blood test, CA199 51.9U / mL (normal range 0 ~ 39U / mL), diagnosed as pancreatic cancer and multiple intrahepatic metastasis, clinical stage cT3N1M1, Ⅳ. 2013-10-01 Application of gemcitabine (Jiangsu Hosen Pharmaceutical Group Co., Ltd., batch number: H20030104) 1.8g intravenously, d1, d8;